Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment

J Alzheimers Dis. 2024;98(1):83-94. doi: 10.3233/JAD-230556.

Abstract

Background: Identifying individuals at risk for mild cognitive impairment (MCI) is of urgent clinical need.

Objective: This study aimed to determine whether machine learning approaches could harness longitudinal neuropsychology measures, medical data, and APOEɛ4 genotype to identify individuals at risk of MCI 1 to 2 years prior to diagnosis.

Methods: Data from 676 individuals who participated in the 'APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease' longitudinal study (N = 66 who converted to MCI) were utilized in supervised machine learning algorithms to predict conversion to MCI.

Results: A random forest algorithm predicted conversion 1-2 years prior to diagnosis with 97% accuracy (p = 0.0026). The global minima (each individual's lowest score) of memory measures from the 'Rey Auditory Verbal Learning Test' and the 'Selective Reminding Test' were the strongest predictors.

Conclusions: This study demonstrates the feasibility of using machine learning to identify individuals likely to convert from normal cognition to MCI.

Keywords: APOE; Aging; Alzheimer’s disease; machine learning; mild cognitive impairment; neuropsychology.

MeSH terms

  • Aging
  • Alzheimer Disease* / diagnosis
  • Alzheimer Disease* / genetics
  • Apolipoproteins E / genetics
  • Cognitive Dysfunction* / diagnosis
  • Cognitive Dysfunction* / genetics
  • Disease Progression
  • Genotype
  • Humans
  • Longitudinal Studies
  • Machine Learning
  • Neuropsychological Tests

Substances

  • Apolipoproteins E
  • ApoE protein, human